PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Apr-2025 Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis ABIVAX
29-Apr-2025 aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024 aap Implantate AG
29-Apr-2025 Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD Takeda
29-Apr-2025 REMINDER: Jaguar Health Hosting April 30 Investor Webcast to Present Initial Results from Proof-of-Concept Study of Crofelemer for the Rare Diseases Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome with Intestinal Failure (SBS-IF) ACCESS Newswire
29-Apr-2025 Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results ACCESS Newswire
29-Apr-2025 Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split ACCESS Newswire
29-Apr-2025 Mainz Biomed Enters into Technology Partnership with EDX Medical Group Mainz BioMed N.V.
29-Apr-2025 Electronic Caregiver Responds to Rural Health Crisis and CMS Leadership Shift: Addison Care Is the Next Step Beyond Telehealth ACCESS Newswire
29-Apr-2025 Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application ACCESS Newswire
29-Apr-2025 Resolutions at BioInvent's Annual General Meeting 2025 ACCESS Newswire
29-Apr-2025 The Hidden Cause of Back Pain No One Talks About - and the Surgeon Who's Changing Everything ACCESS Newswire
29-Apr-2025 Global Isovaleric Acidemia Treatment Market Set for Remarkable Growth to Reach USD 1,125.15 Million by 2033 at a CAGR of 5.6% MARKITWIRED
29-Apr-2025 Myotonic Dystrophy Treatment Market is projected to Reach USD 2,789.35 Million by 2033 at a CAGR of 12.3% | FMI Report MARKITWIRED
29-Apr-2025 Sound Physicians Launches Sound Practice Solutions - a Groundbreaking Approach to Hospital Performance & Revenue Optimization ACCESS Newswire
29-Apr-2025 Myelofibrosis (MF) Treatment Market to reach USD 1,280 Million by 2033; Oral Medication to be Primary Approach to Treatment: FMI Report MARKITWIRED
29-Apr-2025 Global Helicobacter Pylori Infections Treatment Market Poised to Reach USD 1,260 Million by 2033 expand at a 7.04% value CAGR | FMI MARKITWIRED
29-Apr-2025 Global Patient Monitoring Devices Market Set to Soar to USD 125.2 Million by 2032 with a CAGR of 10.5% | Reports FMI MARKITWIRED
29-Apr-2025 Global Joint Replacement Market Set to Reach USD 32.2 Billion by 2035 Amid Rising Demand from Aging Population and Degenerative Joint Disorders | FMI MARKITWIRED
29-Apr-2025 Rising Demand for Neurological Treatments Fuels Growth in the Multiple System Atrophy Therapeutics Market Projected to Reach USD 211.1 Million by 2033 at a 4.4% CAGR | FMI MARKITWIRED
29-Apr-2025 Global Alpha-1 Antitrypsin Deficiency Market to Reach USD 10 Billion by 2033 Amid Surge in R&D Investments and Rising Prevalence of Target Illnesses | FMI MARKITWIRED